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ABSTRACT
Objective: To analyze the quality of life of people with type 2 diabetes mellitus in the three 
levels of the healthcare system. Method: A quantitative, cross-sectional and descriptive 
study carried out in primary, secondary and tertiary healthcare units with individuals in 
outpatient care. The validated Diabetes-39 instrument was used to evaluate quality of 
life. Results: The sample consisted of 53 people. There was a decreasing tendency in the 
quality of life impairment from the primary to the tertiary care levels. In the total sample, 
there were differences between domains of quality of life with the variables gender, 
insulin use and occupation, greater perception of quality of life impairment and disease 
severity in people with higher rates of glycated hemoglobin. Conclusion: Quality of life 
tends to worse as the disease worsens. The results suggest that quality of life is related to 
sociodemographic and clinical variables, therefore, these should be considered in the care.
DESCRIPTORS
Diabetes Mellitus, Type 2; Quality of Life; Nursing Care; Primary Health Care; Health 
Status.
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INTRODUCTION 
In 2017, it was estimated that 425 million people worldwide 
had Diabetes Mellitus (DM), of which 79% lived in developing 
countries(1). Brazil ranked fourth among the 10 countries with 
the highest number of cases of the disease(1), which affected 
approximately 12.5 million people and was among the five 
main causes of death, responsible for more than 59 thousand 
deaths in the year 2015(2).
The chronic hyperglycemic state of DM is associated with 
complications such as cerebrovascular accident, cardiovascular 
disease, renal failure and chronic wounds(3), and with advancing 
age the disease can compromise the Quality of Life (QoL)(4). 
In the present study, the QoL construct will be highlighted 
due to its importance in caring for a person with DM, since 
quality of life can contribute to aggravating the disease or make 
it difficult to treat it. QoL is defined as a perception of the 
individual and their position in the context of the culture and 
value systems in which they live and in relation to their goals, 
expectations and concerns(5). Considering that QoL refers to 
the perception of well-being, studies in this area can provide 
information for caring for people with DM and assist in plan-
ning the treatment and care of this population(6).
The literature differentiates QoL from Health-Related 
Quality of Life (HRQoL), since the latter considers aspects of 
general health, physical functioning, physical symptoms and 
toxicity, emotional, cognitive, social and sexual functions, in 
addition to well-being and existential issues, which may influ-
ence certain aspects of QoL behaviors and perceptions(7). 
A cross-sectional study with 495 Germans with Type 2 
Diabetes Mellitus (DM2) treated in the primary health unit 
showed low HRQoL among females, individuals with low 
education level, physical immobility, chronic pain, emotional 
distress related to DM and high body mass index, and pointed 
out that these characteristics of the sample were associated with 
HRQoL (p <0.05)(8).
Therefore, evaluating HRQoL at different stages of the 
disease may support a holistic approach to care, since changes 
in glucose metabolism may influence the HRQOL of 
these individuals(9).
A hierarchical and decentralized context of the Unified 
Health System (Portuguese acronym: SUS – Sistema Único de 
Saúde) is proposed for care and follow-up of people with DM, 
in which the primary level, considered the “gateway” is the base; 
the secondary level is designated to situations of greater com-
plexity and presence of comorbidities; and the tertiary level is 
designated to the care for disease situations with a higher degree 
of complexity and risk of life(10). 
DM can affect the HRQL due to factors arising from the 
diagnosis itself(9), the treatment(11), the presence of complications 
and associated morbidities(8), among others, as well as intrinsic 
changes in the glucose metabolism of the individuals with the 
disease over time(9).
Thus, the three levels of healthcare play a strategic role in 
SUS, and therefore evaluating the HRQoL of people with DM 
at different moments of the disease will enable to identify fac-
tors that contribute to QoL impairment and subsidize the care 
planning for people with DM.
In view of the above, the present study aimed to analyze the 
HRQoL of people with T2DM in the three levels of healthcare 
and to verify its relation with sociodemographic, clinical and 
laboratory variables in the total sample.
METHOD 
Study type
A quantitative, descriptive and cross-sectional study carried 
out at the Primary Health Care Unit (Portuguese acronym: 
UAPS), Secondary Health Care Unit (Portuguese acronym: 
UASS) and Tertiary Health Care Unit (Portuguese acronym: 
UATS) in the interior of São Paulo from February to July 2015. 
Scenario
Three units were selected to represent the care levels that 
make up the SUS: a primary care unit, a secondary and a tertiary 
unit, in order to contemplate the different moments of treat-
ment and care for people with DM2. 
Selection criteria
Inclusion criteria included persons with T2DM of both 
genders, aged 30 years or older, with diagnosis of DM2 greater 
than or equal to 1 year and being followed up at one of the 
selected health units. Patients who were receiving DM treat-
ment concurrently in another health unit were excluded. 
data collection
The study sample consisted of individuals with T2DM 
who attended the respective units during the data collection 
period (May to August 2015) and who met the proposed 
inclusion and exclusion criteria.
Individuals were invited to participate in the study upon 
return to outpatient appointments or when they came to 
the unit to pick up medications. The sociodemographic and 
HRQoL variables were collected through an individual 
interview, and clinical and laboratory data obtained through 
medical records.
The study was composed of sociodemographic variables: 
gender, age, origin, marital status, schooling in complete 
school years and occupation; clinical variables diagnosis: 
time of DM2, Body Mass Index (BMI), systolic blood pres-
sure (SBP), diastolic blood pressure (DBP), complications 
of the disease and presence of other diseases not related 
to DM2, results of Glycated Hemoglobin (HbA1c) and 
Plasma Fasting Glycemia (FG).
collection inStrument
For the HRQoL data collection, the Diabetes-39 (D-39) 
instrument(12) translated and validated for Brazil(13) was used, 
which consists of 39 items distributed into five domains: 
“Energy and Mobility” (15 items), “Diabetes Control” (12 
items), “Anxiety and Worry” (four items), “Social Burden” (five 
items) and “Sexual Functioning” (three items), which assess 
how much the HRQoL was affected in the last month on a 
scale of one to seven points, in which the score of one represents 
“unaffected QoL”, and seven “extremely affected QoL”(12). In the 
validation study, D-39 showed good internal consistency with 
Cronbach’s alpha of 0.917 for the total score and ranging from 
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0.581 to 0.848 for the domains, showing a valid and reliable 
instrument to measure the HRQOL of people with DM2(13).
This instrument also has two questions about the general 
perception of HRQOL and about the severity of DM. In the 
question about the perception of HRQoL, the score is inverted, 
so that the score “07” represents “higher quality”, and the score 
“01” is “lower quality”(11-12).
Because the number of items is different across the domains, 
the total, minimum, and maximum scores for each domain also 
differs. For the domain “Energy and Mobility” (items: 03, 07, 
09, 10, 11, 12, 13, 16, 25, 29, 32, 33, 34, 35 and 36), the score 
can range from 15 to 105 points; for “Control of Diabetes” 
(items: 01, 04, 05, 14, 15, 17, 18, 24, 27, 28, 31 and 39) from 12 
to 84; for the “Anxiety and Worry” domain (items: 02, 06, 08 
and 22) from four to 48; “Social Burden” domain (items: 19, 20, 
26, 37 and 38) from five to 60; and for the “Sexual Function” 
domain (items 21, 23 and 30) from three to 36, adding up the 
two questions, one about the individual perception of QoL, and 
another about the perceived severity of the disease, both with a 
score of one to seven(14).
In the present study, we followed the instructions of the 
authors who validated the D-39, transforming the scores 
obtained in each section, the total score and the classification 
of self-perception of QoL and the severity of DM into a single 
score ranging from 0 to 100(13) in order to facilitate a compari-
son of statistical domains and analyzes. 
data analySiS and proceSSing 
The data were double-digitized in the Excel Program, vali-
dated, and transported to the Statistical Package for The Social 
Science Program (version 21.0). The results were described as 
mean (standard deviation) and relative and absolute frequencies. 
The Mann-Whitney, Kruskal-Wallis and Chi-square tests 
were used to verify the differences between the groups, and 
the Spearman Correlation Coefficient was used to verify the 
QoL relationship with the sociodemographic variables, clinical 
variables and laboratory tests. An alpha of 0.05 was adopted. 
ethical aSpectS
All the participants signed the Informed Consent Term 
(ICF). This project was approved by the Research Ethics 
Committee of the Universidade of São Paulo at Ribeirão Preto 
School of Nursing, opinion no. 841,962/2014 and complies 
with resolution 466/12, research involving human beings. 
RESULTS
The sample consisted of 53 people, of whom 19 (40.42%) 
were from UAPS, 15 (31.91%) from UASS and 19 (40.42%) 
from UATS. Eighteen people refused to participate in the study 
(five from UAPS, 11 from UASS and two from UATS). The 
sample number for the variables BMI, SBP, DBP, HbA1c and 
FG in each unit corresponded to: UAPS n=19, UASS n=12 and 
UATS n=16. It should be emphasized that the reduction in the 
sample of the variables occurred due to the unavailability of the 
results of these exams in the medical records.
The following are the sociodemographic data, which will be 
presented in the order of the primary care unit to the tertiary 
health unit in Table 1. 
Clinical data showed that people in UASS and UATS were 
overweight (UASS: 27.17 kg/m² and UATS: 29.95 kg/m²) and 
in the UAPS they were obese (32.21 kg/m²)(15). The systolic and 
diastolic blood pressure (UAPS: 122.10/81.36 mmHg, UASS: 
136.00/84.66 mmHg and UATS: 135.68/78.52 mmHg), clas-
sified the users as prehypertensive(16), while fasting blood glucose 
(UAPS: 165.05 mg/dL, UASS: 146.66 mg/dL and UATS: 169 
mg/dL) and HbA1c results (UAPS: 13.37%, UASS: 8.14% 
and UATS: 8.77%) were also altered(17) among the three health 
units (Table 1).
Regarding DM treatment with insulin, it is noteworthy that 
its use was reported by two people (14.1%) in the UAPS, nine 
(60.0%) in the UASS and 16 (84.2%) in the UATS. Regarding 
insulin types, two individuals in the UAPS and six in the UASS 
use NPH insulin and 12 people reported using Regular/Rapid 
human insulin and NPH insulin in the UATS. 
Regarding the HRQOL variable evaluated through the 
D-39, the “Anxiety and Worry” domain obtained the highest 
score among the UAPS and the UASS, while “Energy and 
Mobility” in the UATS. The lowest score was observed in the 
“Social Burden” domain in the three units studied. In the ques-
tion that addressed the perception of HRQOL, the lowest 
score was obtained in the UATS and the highest in the UAPS; 
it should be pointed out that for this question, the higher the 
score, the better the perceived HRQOL. Whereas for the ques-
tion on “Perceived Severity of Diabetes”, there was a lower score 
in UAPS and higher in UATS, which means people seen in the 
UAPS perceived DM as a disease of lesser severity than those 
followed-up by the UATS (Table 2).
When comparing the domain scores with those of the ques-
tions, there was a difference between the studied groups regard-
ing the question “Perceived Diabetes Severity”. Although there 
was no significant difference between the studied groups for the 
other domains, there was an increasing score in the following 
areas: “Energy and Mobility” and “Diabetes Control”, in the 
“Total Classification”, and in the questions: “Perceived general 
quality of life” and “Perceived diabetes severity”, showing that 
HRQOL tends to worsen as the complexity of healthcare levels 
increases (Table 2). 
As a result of the reduced number of participants in the 
present study, the statistical analyzes of the relationship between 
HRQoL and sociodemographic and clinical variables were 
performed in the total sample, without considering the three 
healthcare levels. The results showed that age was negatively 
related to the “Diabetes Control” domain, meaning that the 
lower the age, the better the quality of life related to DM con-
trol. HbA1c was positively related to the “Control of Diabetes” 
domain with the total value of the score, and with the ques-
tion “Perceived diabetes severity”, meaning that the lower the 
HbA1c values, the better the QoL and perception of the sever-
ity of DM (Table 3). 
In comparing HRQoL among the participants’ gender, 
there was a difference in the results obtained in the “Energy and 
Mobility” domains, “Control of Diabetes”, “Social Burden,” and 
“Overall Quality of Life” and “Perceived Diabetes Severity”. The 
scores obtained in these items were higher among females, which 
indicate a higher QoL impairment of the female participants. 
Regarding occupation, the people who work at home achieved 
a higher score in the “Control of diabetes” domain, meaning 
these people had a worse perception of DM control (Table 4).
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The comparison of the participants regarding insulin use 
with the HRQoL showed that the score of people who use it 
daily was higher in the domains: “Energy and Mobility” and 
“Control of Diabetes”, in the “Total QoL”, and in the “Severity 
of Perceived Diabetes” issue, meaning that people who use insu-
lin have worse QoL when compared to those who do not use 
it as a treatment for DM (Table 4).
In comparing HRQoL among people with or without 
morbidities/comorbidities in the studied sample, a differ-
ence between the HRQoL scores was observed among 
those who had a diagnosis of dyslipidemia and complica-
tions related to DM (nephropathy, retinopathy and neu-
ropathy), with those who did not have these diagnoses 
(Table 4).
Table 1 - Socio-demographic and clinical data – Ribeirão Preto, SP, Brazil, 2018.
Variables
Frequency (%)/Mean (standard deviation)
*p-value
UAPS UASS UATS
Gender
Male 10 (52.6%) 07 (46.7%) 06 (31.6%)
**1.805
Female 09 (47.4%) 08 (53.3%) 13 (68.4%)
Age (complete years) 57.37 (15.81) 63.95 (7.96) 59.36 (9.11) *0.259
Marital status
Without a partner  06 (31.6%) 09 (60.0%) 07 (36.8%)
**3.055
With a partner 13 (68.4) 06 (40.0%) 12 (63.2%)
Education level 6.0 (3.66) 5.80 (3.98) 6.21 (4.75) *0.872
Occupation
Active 07 (36.8%) 03 (20.0%) 04 (21.0%)
**7.029
Retired with paid activity 00 (0.0%) 03 (20.0%) 01 (5.3%)
Retired/Pensioner 09 (47.4%) 08 (53.3%) 11 (57.9%)
Works at home, without pay 01 (5.3%) 00 (0.0%) 01 (5.3%)
Unemployed/On leave 02 (10.5%) 01 (6.7) 02 (10.5%)
BMI 32.21 (8.22) 27.17 (4.98) 29.95 (4.64) *0.133
SBP 122.10 (12.39) 136.00 (25.01) 135.68 (21.55) *0.046
DBP 81.36 (23.18) 84.66 (9.15) 78.52 (10.07) *0.088
FG 165.05 (99.34) 146.66 (73.91) 169.61 (81.52) *0.495
HbA1c 13.37 (19.54) 8.14 (1.94) 8.77 (1.95) *0.561
* Kruskal-Wallis test; ** Chi-square test.
Table 2 – HRQL of the sample studied by domains of the D-39 instrument in the three levels of health care – Ribeirão Preto, SP, Brazil, 
2018.
Variables Mean (standard deviation)
 P-value*
D-39 Domains UAPS (n= 19) UASS (n= 15) UATS (n=19)
Energy and Mobility 35.14 (29.64) 41.40 (21.28) 48.12 (26.69) 0.220
Diabetes Control 30.62 (25.59) 32.03 (22.36) 36.47 (22.99) 0.659
Anxiety and Worry 44.07 (29.50) 43.33 (26.80) 47.58 (30.91) 0.782
Social Burden 23.15 (30.27) 14.66 (14.29) 24.21 (29.60) 0.857
Sexual Functioning 30.70 (37.33) 35.92 (40.32) 34.50 (29.25) 0.734
Total classification 32.79 (25.26) 34.87 (18.66) 40.37 (22.44) 0.465
Overall perceived QoL 67.54 (28.58) 65.55 (31.15) 68.42 (26.58) 0.954
Severity of perceived DM 47.36 (32.51) 50.0 (38.31) 76.31 (32.54) 0.024*
Table 3 – Relationship of Quality of Life with sociodemographic and clinical variables of the studied sample – Ribeirão Preto, SP, Brazil, 2018.
Variables
Quality of life (Diabetes-39)
Energy and 
Mobility
Diabetes 
Control
Anxiety and 
Worry
Social 
Burden Sexual functioning Total QoL 
QoL 
Overall
Diabetes 
Severity
Statistical value for the Spearman coefficient (p-value)
Age -0.13 (0.35) -0.32 (0.01) -0.21 (0.11) -0.25 (0.06) -0.19 (0.16) -0.23 (0.08) -0.02 0.87) -0.17 (0.21)
Duration of DM 0.12 (0.36) - 0.02 (0.87) 0.11 (0.44) -0.09 (0.48) -0.12 (0.37) 0.04 (0.72) 0.04 (0.76) 0.22 (0.11)
Education level 0.04 (0.72) 0.05 (0.68) 0.06 (0.62) -0.05 (0.67) -0.04 (0.74) 0.02 (0.87) -0.17 (0.19) -0.06 (0.63)
BMI 0.14 (0.32) 0.04 (0.76) 0.08 (0.57) 0.00 (0.94) -0.10 (0.47) 0.06 (0.66) 0.00 (0.99) 0.04 (0.74)
HbA1C 0.20 (0.16) 0.49 (0.00) 0.22 (0.13) 0.20 (0.16) 0.02 (0.88) 0.35 (0.01) 0.18 (0.21) 0.38 (0.00)
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DISCUSSION 
The HRQoL in the present study was investigated from 
the perception about the possible influences of the DM on 
the daily lives of people across five different domains, includ-
ing two questions on general QoL and severity of DM, 
which make up the D-39 instrument.
The literature shows that it is necessary to follow dietary 
recommendations and regular physical exercises for control-
ling DM; however, when such care becomes insufficient to 
maintain glycemic control, oral antidiabetic therapy is initi-
ated, combined or not with other oral drugs, or even with 
insulin therapy(17). However, behavioral changes and skill 
development are needed in care for treatment success, such 
as monitoring blood glucose, preparing and administering 
insulin, examining the feet, among other actions. 
Disease duration and poor glycemic control favor the 
development of comorbidities that contribute to the aggra-
vation of health, which demands other therapies and special-
ized care and/or treatments. As a consequence, the person is 
referred to health units of greater technological complexity 
in order to receive the treatment according to the degree of 
complexity of their health.
Although there was no significant difference when con-
sidering the value of p <0.05, the results indicate a tendency 
for QoL worsening as the complexity in the healthcare level 
increases. These results have already been shown in a study 
with people attended at the tertiary healthcare level, where 
they perceive their disease with greater severity (p <0.05). 
According to the care characteristics at this care level, these 
results are expected. As the complexity of DM increases, 
the more specialized the care level is for the patient being 
attended(17). 
Studies comparing HRQoL between care levels were 
not identified in the literature, which made it difficult to 
discuss these data; however, a longitudinal study showed 
that HRQoL tends to worsen with worsening of glucose 
metabolism(9) and consequently the levels of complexity of 
attention also intensify. 
Regarding the association of HRQoL and clinical, 
sociodemographic and laboratory data, the present study 
observed a difference between gender, occupation, the treat-
ment and the presence of chronic complications. There was a 
greater perception of QoL impairment and disease severity 
for higher HbA1c rates.
In Saudi Arabia, a cross-sectional study with a sample of 
283 patients with DM2 from a tertiary hospital in Riyadh, 
which used the 36-item Short-Form questionnaire (SF-36), 
showed that increased complications related to DM, gender 
and economic conditions contribute to poorer HRQoL(18).
A cross-sectional study was carried out in Mexico with 
the objective to evaluate the HRQoL by means of D-39 in 
198 people with T2DM of both genders, with a mean age 
of 55 years (SD = 9.7), in an outpatient follow-up at the 
health centers of the metropolitan region, and showed results 
similar to those of the present study, with a higher score in 
the item “Perceived diabetes severity”(19).
Another cross-sectional, multicenter study was con-
ducted in Germany, the United Kingdom, Norway, Australia, 
the United States and Canada to provide the D-39 as an 
Multi-attribute utility-based instrument (MAUI), con-
ducted with 924 people who declared themselves to be car-
riers of DM and users of their respective health services, 
showed that men have higher HRQoL and that women 
obtained worse HRQoL in the domains: “Diabetes Control”, 
“Energy and Mobility” and “Anxiety and Worry”(20).
These results were similar to the present study, in which 
women also obtained lower HRQoL in the “Energy and 
mobility”, “Control of Diabetes,” “Anxiety and worry” 
domains, in addition to “Total quality of life” and the ques-
tion regarding “Perceived diabetes severity”.
A difference in the present study was also found in the 
HRQoL between people who use insulin or not. Those who 
use have had worse HRQoL in the areas of “Energy and 
Mobility”, “Diabetes Control”, “Total Quality of Life” and 
the “Severity of Perceived Diabetes”. 
A cross-sectional study conducted in private units in 
Buenos Aires, Argentina, in a sample of 183 adults with 
DM2, 93 of whom were treated with NPH insulin and 90 
with insulin glargine, through the application of the Audit 
of Diabetes Dependent Quality of Life questionnaire 
(ADDQoL), showed that the domains most affected were 
the following: “Concerns about the Future,” “Freedom to 
Eat,” “Living Conditions,” “Sexual Life,” and “Family Life.” 
This study also highlighted that regardless of sociodemo-
graphic and clinical variables, the use of insulin may affect 
the QoL of patients with DM2(11).
HbA1c is an important parameter of glycemic control. 
The results of the present study showed that the higher the 
HbA1c values (inadequate glycemic control), the worse the 
HRQoL values in the “Control of Diabetes” domain, the 
“Total Quality of Life” and the question on “Perception of 
the severity of diabetes”. 
A descriptive study with 102 people between 30 and 
75 years old and with at least 1 year of diagnosis of T2DM 
carried out in an outpatient unit of a diabetes center in 
Iran, with the objective to evaluate the relationship of QoL 
to glucose and plasma lipids, showed that the increase of 
HbA1c may be related to the worse QoL, since those with 
HbA1c <6.1% had a score of 54.6, while the score in those 
with HbA1c > 6.1 was 1.2, despite no statistical differ-
ence (p=0.573). The instrument used was the World Health 
Organization Quality of Life (WHOQOL-bref ), the abbre-
viated version, in which the score ranges from 0 to 100(6).
In England, 510 adults aged 40 to 69 years were evalu-
ated using the Cambridge screening program (ADDITION 
– Cambridge) to assess the influence of glycemic variations 
on the QoL of people with T2DM over 4 years. The results 
showed that the DM-specific QoL, as evaluated through 
the ADDQoL, is sensitive to glycemic changes, even if the 
disease is well-controlled(4).
The variable age was related to QoL in the “Control of 
diabetes” domain, meaning the younger the individual, the 
better the perception of QoL related to DM control. A similar 
result was found in a cohort study with a sample composed 
7Tonetto IFA, Baptista MHB, Gomides DS, Pace AE
www.ee.usp.br/reeusp Rev Esc Enferm USP · 2019;53:e03424
of 1,158 people with DM2, performed through the DM2 
Strategic Research project in Denmark. This study aimed to 
evaluate the patient’s response to monotherapy, combination 
therapy or the absence of pharmacological intervention for the 
treatment of T2DM in its first year of diagnosis, evidencing 
that younger patients demonstrated better glycemic control 
and maintenance capacity within the parameters of normal-
ity in the three types of proposed therapeutic approaches(21).
As a limitation of the present study, we highlight the 
sample size, which impaired statistical analysis of the QoL 
relationship with sociodemographic and clinical variables 
among the three health care levels. We can also point out the 
difficulty in discussing the data, as there are few published 
studies which used the D-39 instrument. 
CONCLUSION 
In analyzing the respective domains of the D-39 instru-
ment, there was no difference with statistical significance in 
the HRQoL of the people served by the primary, second-
ary and tertiary care units; however, there was a growing 
increase in HRQoL scores, which point to a tendency for 
QoL impairment according to the care complexity.
For p<0.05, there was difference in QoL between gender, 
occupation, treatment and the presence of chronic complica-
tions. For the higher hemoglobin levels, there was greater 
QoL impairment and a greater perception of disease severity, 
and the lower the age, the better the QoL.
Understanding how DM can compromise a person’s 
QoL enables identification of care needs and for planning 
nursing care in an individualized way, and therefore it con-
tributes to improving QoL and controlling the disease.
The results of the present study suggest that the QoL 
of the person with DM may worsen as the care for the 
disease becomes more complex, therefore highlighting 
that investments in primary healthcare are fundamental 
and necessary.
RESUMO
Objetivo: Analisar a qualidade de vida de pessoas com diabetes mellitus tipo 2, nos três níveis de atenção à saúde. Método: Estudo 
quantitativo, transversal e descritivo, realizado em unidades de atenção primária, secundária e terciária à saúde com pessoas em 
atendimento ambulatorial. Utilizou-se do instrumento validado Diabetes-39 para avaliar a qualidade de vida. Resultados: A amostra 
foi constituída por 53 pessoas. Observou-se tendência crescente no comprometimento da qualidade de vida do nível de atenção primária 
a terciária. Na amostra total, houve diferenças entre domínios da qualidade de vida com as variáveis sexo, uso de insulina e ocupação, 
maior percepção do comprometimento da qualidade de vida e gravidade da doença nas pessoas com maiores taxas de hemoglobina 
glicada. Conclusão: A qualidade de vida tende a piorar à medida que a doença se agrava. Os resultados sugerem que a qualidade de vida 
se relaciona com as variáveis sociodemográficas e clínicas, portanto, essas devem ser consideradas no cuidado.
DESCRITORES
Diabetes Mellitus Tipo 2; Qualidade de Vida; Cuidados de Enfermagem; Atenção Primária à Saúde; Nível de Saúde.
RESUMEN
Objetivo: Analizar la calidad de vida de personas con diabetes mellitus tipo 2, en los tres niveles de atención sanitaria. Método: Estudio 
cuantitativo, transversal y descriptivo, realizado en unidades de atención primaria, secundaria y terciaria de salud con personas en 
atención ambulatoria. Se utilizó el instrumento validado Diabetes-39 para evaluar la calidad de vida. Resultados: La muestra estuvo 
constituida de 53 personas. Se observó tendencia creciente en el compromiso de la calidad de vida del nivel de atención primaria a 
terciaria. En la muestra total, hubo diferencias entre dominios de la calidad de vida con las variables sexo, uso de insulina y ocupación, 
mayor decepción del compromiso con la calidad de vida y severidad de la enfermedad en la personas con mayores tasas de hemoglobina 
glicada. Conclusión: La calidad de vida tiende a empeorar a medida que se agrava la enfermedad. Los resultados sugieren que la calidad 
de vida se relaciona con la variables sociodemográficas y clínicas, por lo tanto, esas deben considerarse en el cuidado.
DESCRIPTORES
Diabetes Mellitus Tipo 2; Calidad de Vida; Atención de Enfermería; Atención Primaria de Salud; Estado de Salud.
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